An interventional study of High-intensity interval training (HIIT) - myositis and Standard low-intensity home exercise in Polymyositis and Dermatomyositis, sponsored by Karolinska University Hospital. Status unknown at 1 site in Sweden. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-23.
Sponsored by Karolinska University Hospital · Not applicable, Interventional, and Treatment
Polymyositis and dermatomyositis are rare inflammatory systemic conditions. Reduced muscle function is a cardinal symptom and lung involvement is very common. Knowledge of heart involvement in these patients is very limited, as is knowledge of exercise effects in recent onset, active disease.
The aim of this project is to investigate effects of high-intensity interval training (HIIT) compared to standard low-intensity home exercise as to tolerance, physical capacity, quality of life, depression, disease activity, inflammation, muscle mass/fat mass, muscle metabolism and heart function in patients with recent onset, active polymyositis and dermatomyositis.
This is a randomized controlled trial. Muscle biopsies are taken at time of diagnosis and after 12 weeks of exercise. Muscle biopsies will be analyzed as to baseline kynurenine pathway, calcium release, gene expression and inflammatory infiltrates and as to changes in these parameters following exercise. Muscle function (primary outcome), maximal oxygen uptake, muscle mass/fat mass, disease activity, systolic and diastolic heart function, as well as quality of life and depression is measured at baseline and after 12 weeks of exercise. After all assessments, patients are randomized to HIIT or standard low-intensity home exercise.
The HIIT group will perform 6 sets of 30-60 second biking bouts reaching 85-100% of maximal heart rate, in combination with strength training, three days a week for 12 weeks. The control group will perform a standardized home exercise program five days a week for 12 weeks. After 12 weeks, all assessments are preformed again. If the HIIT is well tolerated, patients in the control group will be invited to HIIT exercise according to the same protocol. Clinical assessments will be performed at 3, 6 and 9 months follow-up in an open extension.
This study will improve our understanding of heart function, muscle metabolism as well as tolerance and effects of intensive exercise as well as heart function early in the disease course and could also improve treatment and prognosis in patients with polymyositis and dermatomyositis.
Patients randomized to the HIIT protocol will train three days a week for 12 weeks. Before exercise start participants will rate self-reported pain and fatigue on a visual analogue scale and describe in own words information about possible changes in medication dose, any side effects from medication as well as possible negative and positive effects from previous exercise sessions, as well as physical activities performed since the previous exercise session. Each exercise session starts with a 5-minut warm-up on about 50% of maximal heart rate. Each HIIT set is between 30-60 seconds where loads are increased and the participant bikes as fast as possible with the goal of reaching >85% of maximal heart rate. During the 2-minuts rest in-between HIIT sets the participant will rate self-reported exertion using the Borg CR-10, 0-10 scale and the Borg RPE scale, 6-20.
When initiating the exercise period, participants start on three HIIT sets on a lower intensity, gradually increasing to goal intensity during the first two weeks. Then the number of sets are gradually increased to six sets.
After completing six HIIT sets the participants perform one set of 10 voluntary repetitions maximum (VRM) resistance training of the deltoids using free weights and of the quadriceps using free weights or a quadriceps curl machine, depending on degree of muscle weakness. Every other week a new 10 VRM is tested and training loads are adapted. After completing each set, the participant rates perceived muscle exertion on the Borg CR-10 scale. The program is ended with stretching of trained muscle groups and rating of overall exertion during the exercise session on the Borg RPE-scale.
Participants randomized to the control group will perform a standardized home exercise program on an easy-to moderate intensity adapted to initial muscle weakness, five days a week for 12 weeks. The program includes tasks for muscle groups targeted by myositis and takes about 15 minutes to perform. In combination with the home exercise program the participants walks 15 minutes on 60% of maximal heart rate. Participants fill out an exercise diary commenting on loads and number of repetitions for each task.
Participants in both groups ware a Polar 330A heart rate monitor during each training session. By synchronizing to a computer program all exercise data are stored in a cloud data base and can be monitored regularly by the project investigator.
184 studies on the registry are indexed under Dermatomyositis; 63 are open to participants now.
This study's planned enrollment of 30 is below the median of 35 across 130 interventional studies indexed under Dermatomyositis.
Browse Dermatomyositis studies →Karolinska University Hospital is the lead sponsor of 279 studies on the registry; 55 are open to participants now.
Compared within Dermatomyositis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Polymyositis. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients with polymyositis and dermatomyositis:
Inclusion Criteria:
Exclusion Criteria:
Healthy controls:
Inclusion Criteria: match a patient for age and gender, exercising not more than twice a week, no neuro- or musculoskeletal disorders.
Exclusion Criteria: Ongoing treatment for cancer, cardiovascular disease contraindicating a maximal oxygen uptake test or HIIT.
12-week, 3d/w, HIIT
Other: High-intensity interval training (HIIT) - myositis
12-week, 5 d/w, home exercise.
Other: Standard low-intensity home exercise
12-week, 3d/w, HIIT.
Other: High-intensity interval training (HIIT) - healthy
12-weeks of 3 days/week HIIT. 6 sets of 30-60 seconds on 85-100% of maximal heart rate performed on a stationary bike followed by resistance training on 10 voluntary repetition maximum.
12 weeks of 5 days/week low-intensity resistance home exercise in combination with outdoor walks of 20 minutes.
12-weeks of 3 days/week HIIT. 6 sets of 30-60 seconds on 85-100% of maximal heart rate performed on a stationary bike followed by resistance training on 10 voluntary repetition maximum.
VO2 max, L/min and ml/kgxmin
A maximal oxygen uptake test with ECG on a stationary bike. For patients with myositis, the test is started on 30W and increasing with 10W every minute until exhaustion. Ventilation and gas exchanges is assessed. Definition of max: ration CO2 / O2 = \>1. The test is stopped when maximal effort according to above definition is reached or when the subjects cannot bike any longer due to exhaustion. Healthy subjects will start on 50W and then follow the same protocol. Subjects rate subjective exertion of thigh muscles, dyspnea on the Borg symptom scale, 0-10. After completion of test overall exertion is rated on the Borg RPE scale, 6-20.
Time frame: 12 weeks
Aerobic capacity, Watt max
A maximal oxygen uptake test with ECG on a stationary bike. For patients with myositis, the test is started on 30W and increasing with 10W every minute until exhaustion. Ventilation and gas exchanges is assessed. Definition of max: ration CO2 / O2 = \>1. The test is stopped when maximal effort according to above definition is reached or when the subjects cannot bike any longer due to exhaustion. Healthy subjects will start on 50W and then follow the same protocol. Subjects rate subjective exertion of thigh muscles, dyspnea on the Borg symptom scale, 0-10. After completion of test overall exertion is rated on the Borg RPE scale, 6-20.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - physician's global assessment.
A myositis-specific protocol in Biodex systems is used. After completing measures of MVIC, the subjects perform six sets of 12, 4-second contractions with a 6-second rest in-between. Set 1: 12 contractions on 20% of MVIC. For each set, intensity is increased by 10%. In the last, 6th set contractions are performed on 70% of MVIC. After each set, a new MVIC is tested. The MDAAT is a valid core set of measures to assess disease activity including physician's and patient's global assessment, measures of muscle strength, activity limitation and extra-muscular organ activity. Physician's global assessment is performed in a Visual Analogue Scale (VAS), 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - patient's global assessment
The MDAAT Patient's global assessment is performed in a Visual Analogue Scale (VAS), 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - Manual Muscle Test
The MDAAT Manual muscle test measures isometric muscle strength in 8 muscle groups with a composite score varying from 0-80, where 8 indicates good muscle strength.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - Health Assessment Questionnaire (HAQ).
The MDAAT, HAQ includes 20 questions about ability to perform daily activities with a composite score varying from 0-3, where 3 indicates severe limitations.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - serum creatine phosphokinase (CK).
The MDAAT, serum CK-levels is measured in mikrocat/L.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - MYOACT constitutional
The MDAAT, MYOACT constitutional (fever, weight loss) is assessed on a VAS, 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - MYOACT heart
The MDAAT, MYOACT heart involvement is assessed on a VAS, 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - MYOACT lung
The MDAAT, MYOACT lung involvement is assessed on a VAS, 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - MYOACT skeletal
The MDAAT, MYOACT skeletal (joint inflammation and bone density) involvement is assessed on a VAS, 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - MYOACT gasto-intestinal tract.
The MDAAT, MYOACT gastro-intestinal tract involvement such as dysphagia is assessed on a VAS, 0-100.
Time frame: 12 weeks
Myositis Disease Activity Assessment Tool (MDAAT) - MYOACT skin
The MDAAT, MYOACT skin involvement (skin rash) is assessed on a VAS, 0-100.
Time frame: 12 weeks
Myositis Damage Index (MDI) - muscle
Degree of skeletal muscle damage is assessed on a VAS, 0-100
Time frame: 6 months
Myositis Damage Index (MDI) - lung
Degree of lung dagame is assessed on a VAS, 0-100
Time frame: 6 months
Myositis Damage Index (MDI) gastro-intestinal tract
Degree of GI-tract damage is assessed on a VAS, 0-100.
Time frame: 6 months
Myositis Damages Index (MDI) Skeletal
Degree of joint damage and osteoporosis is assessed on a VAS, 0-100.
Time frame: 6 months
Myositis Damage Index (MDI) heart
Degree of damage of the heart is assessed on a VAS, 0-100.
Time frame: 6 months
Stress echocardiography
Systolic and diastolic heart function is assessed by ultrasound of the heart.
Time frame: 12 weeks
Inflammatory infiltrates in skeletal muscle
Muscle biopsies are analyzed for inflammatory infiltrates with immunohistochemistry.
Time frame: 12 weeks
Gene expression
Muscle biopsies are analyzed with Micro Array technique
Time frame: 12 weeks
ER-stress
Muscle biopies are analysed by ELIZA
Time frame: 12 weeks
Proteins involved in kynurenine process
Muscle biopsies are analyzed by ELIZA
Time frame: 12 weeks
Proteins involved in calcium release
Muscle biopsies are analyzed by ELIZA
Time frame: 12 weeks
Isometric muscle strength
A myositis-specific protocol in Biodex systems is used. Following several familiarization sets, maximal voluntary isometric contraction (MVIC) is tested until three very similar contractions are recorded. The subjects rest one minute between each MVIC.
Time frame: 12 weeks
Isomteric muscle fatigability
A myositis-specific protocol in Biodex systems is used. After completing measures of MVIC, the subjects perform six sets of 12, 4-second contractions with a 6-second rest in-between. Set 1: 12 contractions on 20% of MVIC. For each set, intensity is increased by 10%. In the last, 6th set contractions are performed on 70% of MVIC. After each set, a new MVIC is tested.
Time frame: 12 weeks
Plan to share: Yes — Muscle biopsies will be sent to Professor Kanneboyina Nagaraju, Professor and Founding Chair, Department of Pharmaceutical sciences, School of Pharmacy and Pharmaceutical Sciences AB-G34, Binghamton University, PO Box 6000 Binghamton, NY 13902-6000. Purpose: To analyse muscle biopsies for micro array analysis.
Supporting information: Analytic code
Time frame: After completion of the project, muscle biopsies from all patients and healthy subjects will be sent to Dr Nagaraju.
Started Oct 2017 (actual). Primary completion is estimated for Dec 2020, 38 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska University Hospital →